Zhang et al. [16] reported that down-regulation of AFAP1-AS1 expression suppressed hepatocellular carcinoma cell growth and metastasis in vitro and in vivo, promoted cell apoptosis, and blocked cell cycle in S-phase through modulating RhoA/Rac2 signaling. Here, RAC2 is linked to hepatocellular carcinoma.